<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04264923</url>
  </required_header>
  <id_info>
    <org_study_id>HGP-0002</org_study_id>
    <nct_id>NCT04264923</nct_id>
  </id_info>
  <brief_title>Evaluation of Stool Microbiome Using HyGIeaCare Prep</brief_title>
  <official_title>Pilot Study: Quality Evaluation of Stool Samples Collected for Microbiome Analysis Using the HyGIeaCare Prep</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HyGIeaCare, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HyGIeaCare, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stool samples will be collected before and during the HyGIeaCare procedure and the samples&#xD;
      will be sent for microbiome evaluation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will have the HyGIeaCare procedure as originally prescribed by their physician.&#xD;
      Before and during the procedure stool samples will be collected and sent to a lab for&#xD;
      microbiome evaluation.&#xD;
&#xD;
      It is anticipated that stool samples collected from the HyGIeaCare prep will provide more&#xD;
      microbiological and biochemical information on the gut interior than using traditional stool&#xD;
      samples.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 27, 2019</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 19, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients between 18 and 80 years old who do not have any known health issues and who have not taken antibiotics within the last two months.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microbial classification</measure>
    <time_frame>6 months</time_frame>
    <description>The number of genes present will be counted</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diversity between stool and colon effluent samples</measure>
    <time_frame>6 months</time_frame>
    <description>Alpha diversity by Shannon diversity index, presence and number of taxa to be documented</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inner diversity of samples</measure>
    <time_frame>6 months</time_frame>
    <description>ANOVA test will be used to acknowledge differences between samples, presence and number of taxa to be documented</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contribution of the variables to samples' diversity</measure>
    <time_frame>6 months</time_frame>
    <description>Principal component analysis (PCoA) will be used to mark significant differences between the samples, taxa will be identified by presence, percentage of sample will be documented</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional genes analysis</measure>
    <time_frame>6 months</time_frame>
    <description>The presence of genes known to represent biochemical functions will be counted and documented</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biosynthetic gene clusters</measure>
    <time_frame>6 months</time_frame>
    <description>Groups of genes with known biosynthetic functions and found to be clustered will be counted and documented together in the different samples</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Stool Microbiome</condition>
  <arm_group>
    <arm_group_label>All patients enrolled</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients enrolled with receive the HyGIeaCare Prep with a new lab sampling technique to be used on all patients enrolled in the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>HyGIeaCare Prep</intervention_name>
    <description>Each patient will have up to 5 stool specimens for evaluation by a lab for microbial contents.</description>
    <arm_group_label>All patients enrolled</arm_group_label>
    <other_name>Stool sample evaluation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient's age is between 18 and 80 years old scheduled for elective screening or polyp&#xD;
             surveillance indicated colonoscopy&#xD;
&#xD;
          2. Patient does not have any known health issues (as listed in exclusion criteria)&#xD;
&#xD;
          3. Patient had not taken antibiotics within the last 2 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient has functional bowel disorders characterized by alternating bowel habits&#xD;
             (diarrhea/constipation), chronic diarrhea or chronic constipation (requiring&#xD;
             pharmacologic prescription treatment)&#xD;
&#xD;
          2. Patient has secondary constipation (colonic obstruction, medications, metabolic cause)&#xD;
&#xD;
          3. Patient has any other condition that, in the opinion of the investigator, may&#xD;
             adversely affect the compliance or safety of the patient or would limit the patient's&#xD;
             ability to complete the study&#xD;
&#xD;
          4. Patient has any of the contraindications listed below:&#xD;
&#xD;
               1. Cardiac: Congestive heart failure (NYHA class III or IV or EF &lt;50%)&#xD;
&#xD;
               2. GI: Intestinal perforation, carcinoma of the rectum, fissures or fistula, severe&#xD;
                  hemorrhoids, abdominal hernia, recent colon or rectal surgery, or abdominal&#xD;
                  surgery, inflammatory bowel disease. History of gastrointestinal surgery- (small&#xD;
                  bowel, colon. Bariatric surgery)&#xD;
&#xD;
               3. GU: Renal insufficiency (CC &lt; 60 ml/min/173m2), cirrhosis with ascites&#xD;
&#xD;
               4. Abdominal surgery within the last 6 months&#xD;
&#xD;
               5. Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David A Johnson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eastern Virginia Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HyGIeaCare Center</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>78744</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>July 24, 2019</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>July 29, 2020</last_update_submitted>
  <last_update_submitted_qc>July 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Initially the data will be used internally.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

